We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Guerbet

Offers products in medical imaging - diagnostic imaging, contrast media - contrast agents, MRI imaging, X Ray imaging... read more Featured Products: More products

Download Mobile App





Guerbet Showcases Ongoing Collaboration with IBM Watson at Radiology Trade Fair

By MedImaging International staff writers
Posted on 26 Nov 2018
Print article
Image: Guerbet featured its digital solutions at the 2018 annual meeting of RSNA (Photo courtesy of IBM Watson).
Image: Guerbet featured its digital solutions at the 2018 annual meeting of RSNA (Photo courtesy of IBM Watson).
Guerbet LLC USA (Princeton, NJ, USA), the US affiliate of the global specialist in contrast agents and solutions for medical imaging, featured its digital solutions, including its ongoing collaboration with IBM Watson Health in medical imaging, at the 2018 annual meeting of the Radiological Society of North America (RSNA).

Guerbet has more than 90 years of experience in the contrast-agent field and offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.

Watson Imaging Patient Synopsis is a radiologist-trained artificial intelligence (AI) tool that extracts relevant patient information, summarized into tailored, specific, and concise single-view reports to better inform diagnostic decisions. Guerbet demonstrated Patient Synopsis alongside its Digital Services offerings at RSNA 2018. Guerbet, an IBM Business Partner, and IBM are finalizing the terms by which Guerbet will become the first reseller of Patient Synopsis. This planned reseller relationship is in addition to IBM and Guerbet's ongoing efforts to co-develop and distribute innovative, clinical decision support solutions. Earlier this year, Guerbet had signed a joint development agreement with IBM Watson Health to develop an AI software solution supporting liver cancer diagnostics and care which will be a great addition to Guerbet's Digital Services portfolio in the near future.

Guerbet's Contrast & Care is also part of its Digital Services offerings and enables radiology departments to collect, archive, examine and share injection data directly with Guerbet's injectors, advancing data transfer and accuracy in dosing to help radiologists best serve patients. Likewise, at the RSNA 2018, Guerbet displayed Imalogix, a cloud-based performance management and dose monitoring solution already available in the US market.

"We are excited to feature Watson Imaging Patient Synopsis, Contrast & Care and Imalogix at this year's RSNA," said Massimo Carrara, Guerbet Vice President for North America. "Our products and commercial partnerships with cutting-edge Digital Solutions affirm our commitment to offering the 'best of the best' in diagnostic and interventional imaging, and support Guerbet's five-year plan to capture growth opportunities and move toward a new and innovative future of medical imaging."


Print article
CIRS -  MIRION
Radcal

Channels

MRI

view channel
Image: Hyperpolarized MRI technology reveals changes in heart muscle’s sugar metabolism after heart attack (Photo courtesy of ETH Zurich)

MRI Technology to Visualize Metabolic Processes in Real Time Could Improve Heart Disease Diagnosis

Magnetic resonance imaging (MRI) has become an indispensable part of medicine. It allows unique insights into the body and diagnosis of various diseases. However, current MRI technology has its limitations:... Read more

Ultrasound

view channel
Image: A combination of ultrasound and nanobubbles allows cancerous tumors to be destroyed without surgery (Photo courtesy of Tel Aviv University)

Ultrasound Combined With Nanobubbles Enables Removal of Tumors Without Surgery

The prevalent method of cancer treatment is surgical removal of the tumor, in combination with complementary treatments such as chemotherapy and immunotherapy. Therapeutic ultrasound to destroy the cancerous... Read more

General/Advanced Imaging

view channel
Image: AI tool predicts reduced blood flow to the heart (Photo courtesy of Pexels)

AI Tool Uses CT Scans to Identify Patients at Risk of Reduced Blood Flow to the Heart

Blockages of the coronary arteries typically occur due to the buildup of fatty plaques. This may restrict blood flow to the heart, causing chest pain, heart attacks, or even death. Identifying which arteries... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.